Insights from real-world data: clinical features and treatment patterns of Compound Jinqiancao Granules in patients with prostatitis
June 2026
in “
Frontiers in Pharmacology
”
Related Community Posts Join
6 / 1000+ resultscommunity Currently participating in the Extended Phase III clinical trial of Pyrilutamid in China
in Technology 81 upvotes 2 years ago A user from China is participating in a clinical trial for Pyrilutamid, a potential hair loss treatment originally developed for prostate cancer. They've experienced no side effects except initial scalp itchiness, and will share results after the year-long trial.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
in Research/Science 133 upvotes 2 years ago The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Anagenic is trying to compound Gt20029
in Treatment 56 upvotes 3 years ago The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.
community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China
in Technology 13 upvotes 5 years ago The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.
community [Part 2] – Sharing data for collaborative analytics on pyrilutamide
in Research/Science 3 years ago Analyzing data on pyrilutamide, a potential hair loss treatment, as well as the effectiveness of other treatments such as Minoxidil, Finasteride, and RU58841.
community Potentially Positive Pyrilutamide News Coming
in Research/Science 6 upvotes 3 months ago Kintor Pharmaceutical's stock rise suggests potential positive news about Pyrilutamide, a topical anti-androgen. GT20029 may also compete with existing treatments like finasteride and dutasteride.
Similar Research
5 / 1000+ resultsresearch Treatment response to conventional and novel therapies in chronic prostatitis
July 2003 in “Current Prostate Reports” Combining different treatments may be needed to effectively manage chronic prostatitis.
research Saw palmetto and finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome
March 2005 in “Current Prostate Reports”research Treatment Response to Conventional and Novel Therapies in Chronic Prostatitis
7 citations , July 2003 in “Current Urology Reports”research Treatment of chronic prostatitis/chronic pelvic pain syndrome
50 citations , January 2008 in “International Journal of Antimicrobial Agents” Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.
research Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management1
35 citations , May 2002 in “Journal of the European Academy of Dermatology and Venereology” Chronic pelvic pain in men is common, but its cause is unknown and treatments are often ineffective.